COVID-19 Impact on the Worldwide Sales of Immunology Drugs

    NEXT STORY
    Swab And Viral Transport Medium Market Value Anticipated To Reach US$ 900 Million By 2027: Acumen Research And Consulting
    PREV STORY
    REPEAT — Pure Extracts and Canada House Wellness Group sign agreement to distribute concentrate products through existing provincial distribution channels
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Chi-Med to Announce 2018 Final Results

    LONDON, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) ...

    author_avatar
    NASDAQ Market News

    Chi-Med Announces NDA Acceptance in China for Surufatinib in Non-Pancreatic Neuroendocrine Tumors

    author_avatar
    NASDAQ Market News

    AB Science: New independent research reveals that masitinib has direct anti-viral activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating COVID-19

    author_avatar
    NASDAQ Market News